Menu

Author Nets Seven Retractions

Biochemical Pharmacology pulls papers coauthored by a scientist whose work has been under investigation at MD Anderson Cancer Center.

Feb 22, 2016
Kerry Grens

WIKIMEDIA, ELKE WETZIG

Biochemical Pharmacology this week retracted seven papers from Bharat Aggarwal, who has studied the physiological effects of curcumin at MD Anderson Cancer Center. As Retraction Watch reported today (February 22), all of the retraction notices state that “the data integrity has become questionable.”

In all seven papers, figures were reused (and, in cases, manipulated to represent different results), according to the retraction notices.

Aggarwal is the subject of an institutional investigation and already has corrections, expressions of concern, and two “withdrawals” to his name.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.